SAR442085

· Sanofi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAR442085, covering 2025-09-12 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma [Phase 1]